Integrated Regulation of Very Low Density Lipoprotein Triglyceride and Apolipoprotein-B Kinetics in Non-insulin-dependent Diabetes Mellitus

Turnover rates of plasma very low density lipoprotein (VLDL) triglyceride (TG) and apolipoprotein-B (apo-B) were significantly increased in age- and weight-matched groups of normolipemic and hyperlipemic mild diabetics, and hyperlipemic moderately severe diabetics when compared with normolipemic controls. As in the normolipemic subjects, a significant correlation between VLDL TG and apo-B turnover rates was found in all diabetic groups, suggesting that integration of TG and apo-B production at synthetic and/or secretory sites is retained in diabetes, thus resulting in increased secretion of VLDL particles of normal composition. In normolipemic mild diabetic subjects, the fractional turnover rates of VLDL TG and apo-B were also significantly increased so that increased removal accompanied increased VLDL production. In the hyperlipemic diabetics, however, the fractional turnover rates were significantly reduced, hence the increased in VLDL removal was not sufficient to compensate for enhanced production. In normolipemic mild diabetic patients, low density lipoprotein (LDL) formation was increased, only a small fraction of VLDL apo-B being removed via a non-LDL pathway, presumably as remnant VLDL. In hyperlipemic mild diabetics, removal of VLDL apo-B via both the LDL and non-LDL pathways was increased. In hyperlipemic moderately severe diabetes, LDL formation was not increased; catabolism of VLDL apo-B through the non-LDL route was however, fivefold > normal. We conclude that increased VLDL secretion is a fundamental defect in non-insulin-dependent diabetes. In hyperlipemic individuals, VLDL removal is also impaired. The increase in LDL and/or VLDL remnant formation, regardless of prevailing plasma lipid levels or the severity of diabetes, provides a source of cholesterol which may account for the atherogeneity of this disorder.

[1]  A. Kissebah,et al.  Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. , 1981, Metabolism: clinical and experimental.

[2]  J. Olefsky Lilly Lecture 1980: Insulin Resistance and Insulin Action: An In Vitro and In Vivo Perspective , 1981, Diabetes.

[3]  D. Steinberg,et al.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. , 1980, The American journal of physiology.

[4]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[5]  S. Grundy,et al.  Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects. , 1979, The Journal of clinical investigation.

[6]  P. Nestel,et al.  Catabolism of very low density lipoprotein B apoprotein in man. , 1978, The Journal of clinical investigation.

[7]  M. Kállai,et al.  The metabolic heterogeneity of human very low density lipoprotein triglyceride. , 1977, Metabolism: clinical and experimental.

[8]  N. B. Myant,et al.  The passage of apoproteins from plasma lipoproteins into the lipoproteins of peripheral lymph in man. , 1977, Clinical science and molecular medicine.

[9]  B. Lewis,et al.  Metabolism of Very Low Density Lipoproteins in Hyperlipidaemia: Studies of Apolipoprotein B Kinetics in Man , 1976, European journal of clinical investigation.

[10]  R. Havel,et al.  Quantification of triglyceride transport in blood plasma: a critical analysis. , 1975, Federation proceedings.

[11]  R. Havel,et al.  Apoprotein composition of very low density lipoproteins of human serum. , 1975, The Journal of clinical investigation.

[12]  B. Lewis,et al.  Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. , 1975, The Journal of clinical investigation.

[13]  J. Brunzell,et al.  Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. , 1975, The Journal of clinical investigation.

[14]  D. Porte,et al.  Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). , 1975, Metabolism: clinical and experimental.

[15]  A. Motulsky,et al.  Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities. , 1975, Metabolism: clinical and experimental.

[16]  G. Reaven,et al.  Reappraisal of the role of insulin in hypertriglyceridemia. , 1974, The American journal of medicine.

[17]  G. Schonfeld,et al.  Apolipoprotein B Levels and Altered Lipoprotein Composition in Diabetes , 1974, Diabetes.

[18]  E. Nikkilä Plasma triglycerides in human diabetes. , 1974, Proceedings of the Royal Society of Medicine.

[19]  A. Kissebah,et al.  The Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Patients with Idiopathic Hypertriglyceridaemia and Their Relation to Carbohydrate Metabolism , 1974 .

[20]  A. Chait,et al.  Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. , 1974, Lancet.

[21]  S. Eisenberg,et al.  Very low density lipoprotein "remnant" particles: uptake by aortic smooth muscle cells in culture. , 1973, Biochimica et biophysica acta.

[22]  A. Chait,et al.  Plasma Triglyceride and Fatty Acid Metabolism in Diabetes mellitus , 1972, European journal of clinical investigation.

[23]  E. Nikkilä,et al.  Measurement of plasma triglyceride turnover in the study of hyperglyceridemia. , 1971, Scandinavian journal of clinical and laboratory investigation.

[24]  D. Steinberg,et al.  Transport of plasma free fatty acids and triglycerides in man: a theoretical analysis. , 1970, The Journal of clinical investigation.

[25]  H. Hart,et al.  Rate of Initial Entry of Ca47 and Sr85 from the Intestine into the Vascular Space.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  G. Reaven,et al.  Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. , 1965, The Journal of clinical investigation.

[27]  E. Bierman,et al.  The Hyperlipemic Effect of a Low-fat, High-carbohydrate Diet in Diabetic Subjects , 1961, Diabetes.

[28]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  O. Faergeman Metabolism of plasma lipoproteins. , 1977, Acta medica Scandinavica. Supplementum.

[30]  E. Nikkilä,et al.  Plasma triglyceride transport kinetics in diabetes mellitus. , 1973, Metabolism: clinical and experimental.

[31]  P. Barter,et al.  Precursor-product relationship between pools of very low density lipoprotein triglyceride. , 1972, The Journal of clinical investigation.

[32]  E. Nikkilä,et al.  Control of plasma and liver triglyceride kinetics by carbohydrate metabolism and insulin. , 1969, Advances in lipid research.

[33]  F. Hatch Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[34]  D. Porte,et al.  A concept of the pathogenesis of diabetic lipemia. , 1966, Transactions of the Association of American Physicians.

[35]  G. Reaven,et al.  VALIDATION OF AN INCOMPLETELY COUPLED TWO-COMPARTMENT NONRECYCLING CATENARY MODEL FOR TURNOVER OF LIVER AND PLASMA TRIGLYCERIDE IN MAN. , 1965, Journal of lipid research.